Sleep Apnea Diagnostics Market: Global Opportunity Analysis & Industry Forecast

1. Download Report Sample

2. The global sleep apnea diagnostics market was valued at $290.50 million in 2020, and is projected to reach $545.09 million by 2030, registering a CAGR of 6.7% from 2021 to 2030. Sleep apnea is a sleeping disorder that can lead to serious health problems, including hypertension (high blood pressure), stroke, cardiomyopathy (enlargement of the muscle tissue of the heart), heart failure, diabetes and heart attacks. Untreated sleep apnea causes breathing to stop repeatedly during sleep, causing loud snoring and daytime tiredness, even with a full night’s sleep. Sleep apnea can affect anyone, but most often older men who are overweight. Sleep apnea occurs in about 25% of men and nearly 10% of women. It can affect people of all ages, including babies and children and particularly people over the age of 50 and those who are overweight. Certain physical traits and clinical features are common in patients with obstructive sleep apnea. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4666 Sleep Apnea Diagnostics Market Download Report Sample

3. The growth of the global sleep apnea diagnostics marketis driven by significant increase in the incidence of sedentary lifestyle disorders, including obesity, diabetes, and hypertension, working in shifts & stressful working environments cause sleep apnea, and various technological advancements in sleep apnea diagnostics devices. However, high cost of sleep apnea diagnostics and lack of awareness about the sleep apnea pose to restrain the growth of the sleep apnea diagnostics market. Conversely, untapped markets of developing economies are expected to offer lucrative opportunities during the forecast period.   The global sleep apnea diagnostics market is segmented into product, end user, and region. Depending on product, the market is fragmented into polysomnography (PSG) devices, actigraphy systems, respiratory polygraph, sleep apnea screening device, oximeter. On the basis of end user, it is bifurcated into hospital & sleep lab and homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/4666 Sleep Apnea Diagnostics Market Download Report Sample

4. By product, the polysomnography device (PSG) segment was the major revenue contributor in 2020, and is expected to maintain this dominance throughout the forecast period. This is attributed to the wide use of PSG devices in hospitals & sleep labs, as PSG enables the doctor to monitor varied parameters of sleep apnea, such as brain activity, muscle activity, and breathing activity to get a comprehensive interpretation of what disorder the patient is suffering from. On the basis of end user, the market is divided into hospital & sleep lab and homecare. The hospital & sleep lab segment dominates the global sleep apnea diagnostics market, owing to the preference among patients to visit hospitals for the diagnosis of sleep apnea. North America accounted for the highest market share in 2020, due to availability of advance therapeutics, higher spreading of awareness, and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. Pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth. Customization request @ https://www.alliedmarketresearch.com/request-for-customization/4666 Sleep Apnea Diagnostics Market Download Report Sample

5. The Major Key Players Are: • Cadwell Industries Inc • Devilbiss Healthcare • Koninklijke Philips N.V. (Philips) • Medtronic Plc • Mindray Medical International Limited • Natus Medical Incorporated • Nihon Kohden Corporation • Resmed Inc • Smiths Group Plc. (Smiths MEDICAL) • Somnomedics GMBH Sleep Apnea Diagnostics Market Download Report Sample

6. Key Findings of the Study: • On the basis of product, the polysomnography device (PSG) segment held largest market share in 2020 and is expected to remain dominant throughout the forecast period. • On the basis of end user, hospital & sleep lab segment held largest market share in 2020 and is expected to remain dominant throughout the forecast period. • On the basis of region, North America is expected to experience growth at the highest rate, registering a CAGR of 5.7% during the forecast period. Sleep Apnea Diagnostics Market Download Report Sample

7. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Sleep Apnea Diagnostics Market Download Report Sample